Raising Cervical Cancer Awareness

by | Jan 18, 2018

Find out how cervical cancer awareness has grown drastically in the last 20 years & why the U.S. government designated January to help educate.

Today we continue “DRops of Wisdom,” our physician blog, with Dr. Ron Schonwetter, chief medical officer for Chapters Health System. He describes the importance of raising cervical cancer awareness during the month of January.

January is Cervical Cancer Awareness Month

Over the last two decades, awareness of cervical cancer has grown significantly. This is due in large part to the National Cervical Cancer Coalition, whose mission is to help women, family members and caregivers battle the personal issues related to cervical cancer and promote prevention through community education.   Subsequently, the U.S. government designated the month of January to also raise awareness about this form of cancer.

According to the American Cancer Society, approximately 13,240 new cases of invasive cervical cancer will be diagnosed and about 4,170 women will die from cervical cancer in the United States in 2018. Today, cervical pre-cancer is identified more often than the invasive form of cervical cancer.

Years ago, cervical cancer was one of the most common types of cancer that resulted in death for women in the United States. With the advent and increase in usage of Pap tests, the cervical cancer death rate decreased dramatically due to much earlier diagnoses.

How has this screening test helped? Before cancer even starts to develop in the cervix, a Pap test can recognize subtle changes. And if cervical cancer has started to evolve, this screening test identifies the change earlier on, when it’s easier to treat and cure.  In 1971 when President Nixon signed the National Cancer Act and introduced the federal mandate “war on cancer,” the five-year survival of women with Stage 0 cervical cancer was less than 50 percent compared to 93 percent today.

Who is At Risk?

Women between the ages of 35 and 54 are most at risk for developing cervical cancer. It is rare in women younger than 20. Nevertheless, older women need to understand that they aren’t without risk as well. In fact, the percent of new cases of cervical cancer in women over the age of 65 is almost 20 percent of all new cases diagnosed.

In looking at ethnicity, Hispanic women are the population with the highest rates of cervical cancer. They are followed by African Americans, Caucasians and Asians.

What predisposes a woman toward cervical cancer? There are several risk factors that can increase a woman’s risk in developing this form of cancer.

Risk factors are:

  • Human papillomavirus (HPV): Over the last couple of years, there has been an increase in spreading the word about this most important risk factor for cervical cancer. Some individuals who are not able to rid their body of HPV develop a chronic infection, which greatly increases their risk of developing cervical cancer.
  • Weak immune system: As with other forms of cancer, a weak immune system puts individuals at high risk due to the fact that the body isn’t able to destroy or curtail the growth and spread of cancer cells or infections such as HPV. For example, cervical pre-cancer can rapidly become invasive in a woman who also has HIV.
  • Smoking: Any woman who smokes tobacco puts herself at almost double the risk of developing cervical cancer. Studies have demonstrated that the by-products of tobacco damage the DNA in the cervix. Smoking also can weaken the immune system in fighting HPV infections.
  • Chlamydia: This common bacterial infection gravitates to a woman’s reproductive organs. Like HPV, this infection is spread via sexual contact and most women do not experience any symptoms. According to a study published in JAMA, research confirmed a high risk of cervical cancer in women who had past or current chlamydia infections, which were then verified by blood tests and cervical mucus.
  • Family history: As with breast cancer, a mother or sister with cervical cancer increases a woman’s chance of developing this disease. This may be due to a family tendency to inherit the inability for women to fight off HPV infections.

cervical cancer awareness

Dispelling 3 Cervical Cancer Myths

In our society, there always seem to be various topics that are fraught with myths and misconceptions. So today, we are tackling the topic of cervical cancer and setting the record straight.

Myth #1: Cervical cancer can’t be treated.

If detected and diagnosed early, cervical cancer can be treated effectively. Thus, it is very important to have routine preventive screenings even if no symptoms are present.

Myth #2: Older women don’t need Pap smears.

All women, who are 21 years or older, need periodic and regular Pap smears until the age of 65. After that age, women should discuss with their physicians the risks and benefits of ongoing screening based on their specific circumstances.

Myth #3: The Human papillomavirus (HPV) infection is not common.

HPV is common and the most important risk factor for developing cervical cancer. It is transmitted via skin-to-skin contact and bodily fluids. It is estimated that approximately 80 percent of Americans will contract HPV sometime during their lifetime. Oftentimes, people don’t experience any HPV symptoms, such as visible genital warts, and thus may never know they had/have HPV. Women learn that they contracted HPV when their screening test comes back positive. An abnormal Pap test can be related to HPV, but many times physicians don’t relay this information to their female patients. Therefore, many women do not know or understand the link between HPV and cervical cancer.

A vaccine to prevent HPV was first developed in 1991 by researchers Ian Frazer and Jian Zhou at the University of Queensland. It was then patented in the United States, and introduced as a tactic to combat HPV spread by the Centers for Disease Control (CDC). Today the CDC recommends that the vaccine be given to preteen girls and boys at age 11 or 12. The reasoning behind this recommendation is that these children will be protected before ever being exposed to HPV. This vaccine is actually a series of two vaccines given six to twelve months apart. If given over age 14, three shots are needed over a six month period.

Discover more details and information about care for patients with cancer.

For more information, please call our helpful Chapters Health team at 1.866.204.8611 or Contact Us.

Phoebe Ochman

Phoebe Ochman

Phoebe Ochman, director of corporate communications for Chapters Health System, manages all content and communications for the nonprofit organization. Email: [email protected]

About Us

Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through its radical approach to healthcare that leverages a one-of-a-kind system to support patients, families, and caregivers across the country, while remaining grounded in the mission of taking care of patients, or taking care of those who do®.

Learn More

Chapters Health System Announces Selection on Hospital and Health System CFOs to Know

Willamette Vital Health Finalizes Affiliation with Chapters Health System

Nathan Adelson Hospice Finalizes Affiliation with Chapters Health System

Andrew Molosky Makes Becker’s Hospital Review 2025 Great Leaders in Healthcare List

Andrew Molosky on podcast

John J. Whyte, MD, MPH

CEO and Executive President,
American Medical Association

John Whyte, MD, MPH serves as the CEO and Executive Vice President of the American Medical Association, the nation’s largest physician organization.

Prior to the AMA, Dr. Whyte served as the Chief Medical Officer at WebMD, leading initiatives that expanded strategic partnerships, created new business opportunities, and positioned WebMD at the forefront of digital health innovation. He was a pivotal force in evolving WebMD’s digital platforms from content delivery engines to powerful tools connecting consumers directly to care, establishing critical new revenue models. He is a recognized leader in healthcare delivery and regulation and is consistently named as one of the Top 20 Health Influencers.

Before joining WebMD, Dr. Whyte served as Director of Professional Affairs and Stakeholder Engagement at the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research. There, he spearheaded groundbreaking initiatives to modernize clinical trial design, expand diversity in research, and advance the regulatory use of real-world evidence — efforts that continue to impact patient-centered drug development today.

Earlier, as Chief Medical Expert and Vice President of Health and Medical Education at Discovery Channel, Dr. Whyte launched educational programming that captured both medical and mainstream audiences, successfully aligning mission-driven health education with corporate funding strategies and building new multimedia brand identities.

At the Centers for Medicare & Medicaid Services (CMS), Dr. Whyte played a pivotal role in formalizing Medicare’s national coverage decision process, directly shaping payment policies and advancing innovative models to improve healthcare outcomes. His experience at CMS demonstrates a deep understanding of health policy, reimbursement strategies, and the critical intersection of clinical innovation and payment models.

A board-certified internist, Dr. Whyte completed his MD at Hahnemann University School of Medicine, his residency at Duke University Medical Center and earned his MPH in Health Policy and Management at Harvard University. He previously served as a health services research fellow at Stanford University. An accomplished author, Dr. Whyte has written extensively for both professional and consumer audiences, including five best-selling book

Andrew Molosky on podcast

Dr. Venki Ramakrishnan

Nobel Laureate

Venki Ramakrishnan is an American and British molecular biologist who shared the 2009 Nobel Prize in Chemistry. He currently works at the world-renowned MRC Laboratory of Molecular Biology in Cambridge, England and from 2015-2020, he served as President of the Royal Society, one of the world’s oldest scientific organizations. He is best known for his work on protein synthesis, the process by which genetic information is used by the ribosome to make the thousands of proteins that make life possible. This process is fundamental to all life and its dysfunction leads to many diseases as well as to aging. He is a member of the US National Academy of Sciences and was knighted by the British government in 2012. In 2022, he received one of Britain’s highest civilian honors, the Order of Merit, which is restricted to 24 people across all fields.

In addition to his academic work, Ramakrishnan is a science partner of the venture capital fund Ahren Innovation Capital, and on the boards of the AI-based drug development company, Isomorphic Labs, and the British Library. He recently co-founded RNAvate, an RNA therapeutics company based on stable, next-generation RNA molecules. In the public arena, he played a leadership role when he was president of the Royal Society, including dealing with the consequences of Brexit and helping convene the Society’s response to provide advice during the covid pandemic and did a significant amount of public engagement including articles in the press and appearances on national media.

Ramakrishnan is the author of two popular books: Gene Machine (2018), a very frank scientific memoir about the race for the structure of the ribosome that led to the Nobel Prize; and Why We Die: The New Science of Aging and the Quest For Immortality (2024), which looks at the biology of aging and efforts to combat it.

Andrew Molosky on podcast

Marwa El-Menshawi, MD, MPH

Chief Operating Officer, PACE Chapters Health System

Marwa El-Menshawi, MD is the Chief Operating Office for Hope PACE. She is a triple board-certified physician, specializing in Family, Geriatric and Hospice Medicine. Dr. El-Menshawi's focus is on improving the lives of those affected by advanced age and serious illness through innovation in high complexity and value-based care. She has almost 20 years of clinical, academic and healthcare leadership experience.

Dr. El-Menshawi is a member of the American Academy of Family Medicine and the National PACE Association. She serves on the Mayor's Committee for Livability and Healthy Aging, focused on serving the community through advocacy and education, recommending and promoting programs and initiatives that benefit older adults.

Dr. El-Menshawi earned her Medical Doctorate as a Magna Cum Laude graduate from the University of Alabama School of Medicine and was awarded the distinguished membership into the Alpha Omega Alpha medical honors society, along with multiple academic achievement awards including the American Medical Women's Association Glasgow-Rubin Achievement Citation, the Merck Manual Award and the Peacock Teaching Fellowship. She completed her residency in Family Medicine and Certificate of Added Qualifications in Geriatric Medicine following a Geriatrics Fellowship at Advent Health in Orlando, FL. She serves as a Clinical Assistant Professor of Geriatrics at the Florida State University College of Medicine and an Assistant Professor of Family Medicine at the University of Central Florida College of Medicine.

Andrew Molosky on podcast

Andrew Molosky

President and CEO, Chapters Health System

Andrew Molosky is the President and Chief Executive Officer of Chapters Health System, the country's defining chronic illness organization, comprised of more than 30 different companies and programs, including the nation's largest nonprofit hospice network, PACE, value-based care such as CareNu, a Medicare Advantage plan, managed services organizations, technology solutions, advanced illness offerings, and more.
Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through Molosky's innovative approach to healthcare, becoming a national leader recognized by Great Places to Work, Fortune, USA Today, and others for being a top place to work.
As a leading voice in healthcare, Molosky is routinely engaged as a consultant, speaker, and mentor. Molosky is modeling and leading across several industries concurrently.
Molosky has more than 20 years of experience spanning an array of geographies and organizations, including publicly traded, privately held, and nonprofit. He completed his undergraduate work at the University of Toledo and his Master of Business Administration from the Ken Blanchard College of Business at Grand Canyon University, additionally holding his Fellowship from the American College of Healthcare Executives.

Share This